United States: Awful Missouri Venue/Joinder Ruling Offers Way Out – Take It!

Last Updated: November 21 2016
Article by James Beck

Even after having read it through twice, we find the result in Barron v. Abbott Laboratories, Inc., ___ S.W.3d ___, 2016 WL 6596091 (Mo. App. Nov. 8, 2016), hard to fathom, and even harder to stomach. For several years after starting the blog, one of our aphorisms was "nothing good ever comes out of Missouri." Then legal developments caused us to retire that slogan. Now we may have to bring it back – maybe.

Barron affirmed a $48 million verdict – concerning birth defects – against the maker of a drug that had a black box warning – about birth defects


Barron, 2016 WL 6596091, at *1.

Astonishingly, this boxed warning, which only the FDA can mandate, was a sufficiently inadequate advisory that the drug could cause birth defects that a St. Louis (City) jury awarded $23 million in punitive damages to the plaintiff, who was from Minnesota.

And those two places – St. Louis City and Minnesota – are as much the problem as the "Show-Me-The-Money State" verdict itself. Barron is a poster child for venue and joinder run amok. First, the underlying action was filed by 24 plaintiffs from all over the country (13 different states), with nothing in common save claiming somewhat similar injuries to different persons from the same drug. Id. at *4. Of course, a couple of plaintiffs were from Missouri (and another presumably from the home state of a defendant), in order to defeat diversity. Id. at *2.

However, Missouri's venue and joinder rules, at least the way that courts like Barron have interpreted them, make no sense and lend themselves to blatant forum shopping and litigation tourism. That is how a Minnesota plaintiff, injured in Minnesota, was able to try a case in St. Louis City, even though neither that plaintiff nor the defendant had anything to do with that venue.

This brew starts with lumping together almost unlimited (except by CAFA's 100-plaintiff "mass action" provision) numbers of plaintiffs who allegedly took the same product and claim the same general category of injury. This sort of polyglot complaint – prohibited in federal court and in almost every other state (we remember the Mississippi Supreme Court doing away with a similar regime) – is allowed under the current construction of Mo. R. Civ. P. 52.05(a), which provides:

All persons may join in one action as plaintiffs if they assert any right to relief jointly, severally, or in the alternative in respect of or arising out of the same transaction, occurrence or series of transactions or occurrences and if any question of law or fact common to all of them will arise in the action.

The first part of this sentence, "the same transaction, occurrence or series of transactions or occurrences," is simply the standard language of Fed. R. Civ. P. 20, which alone does not support joining unrelated plaintiffs simply because they claim similar product-related injuries.

Additional Missouri language, however − beginning with "and" – imposes the requirement that "any question of law or fact common to all of them." As anybody who has ever learned about Venn Diagrams knows, "and" is a limiter, meaning that the resultant universe must share both characteristics. Not in Missouri, however, which seems to treat the "and" clause of Rule 52.05(a) as expansive, requiring only that the "transactions"/"occurrences" "be related by a common question of law or fact." Barron, 2016 WL 6596091, at *3. This is reminiscent of the dumbing down of the commonality requirement in Fed. R. Civ. P. 23, until Wal-Mart Stores, Inc. v. Dukes, 564 U.S. 338, 349-50 (2011), put a stop to it. The same "commonalities" that are insufficient to support permissive joinder under other jurisdiction's "transactions"/"occurrences" language are enough in Missouri:

[T]he commonalities among the 24 plaintiffs are, first and foremost, each alleged birth defect injuries from the drug . . ., which their mothers took by prescription during their pregnancies. The plaintiffs alleged Appellant is the only manufacturer, seller, and marketer of [the drug] and, as such, was responsible for proper warnings.

* * * *

Missouri law clearly allows for the joinder of unrelated plaintiffs who allege injury from the same conduct of the same defendant.

2016 WL 6596091, at *3-4 (citations omitted). These "commonalities" permitted joinder notwithstanding the plaintiffs being from different states, taking the drug across an 18-year period, with different exposures, different physicians, "different circumstances," and alleging different birth defects. Id. at *4.

The fact [the drug] was prescribed to the plaintiffs by different physicians is not controlling on the question of joinder. Nor are the claimed differences in the . . . birth defects sustained by the plaintiffs the issue here. The differing ages and home states of the plaintiffs have no bearing on the commonality of their claims or the relevant transaction by Appellant.

Id. (citation omitted). These "differences do nothing to disprove the commonalities, and it is the commonalities that permit joinder." Id. That's the first problem with Missouri procedure that Barron illustrates – and perpetuates − anything goes product liability joinder.

Bad as this is, the second problem may be worse – that's the Missouri venue statute. Free joinder of scores of unrelated plaintiffs has allowed the other side to exploit a flaw in the statute and push any multi-plaintiff action into St. Louis City whenever they want (effectively all of them) simply by including a resident or two from the City. As Barron explains:

Appellant claims the only potentially proper Missouri venue for tort claims in which . . . plaintiff was first injured outside of Missouri is the county in which Appellant's registered agent is located, which is St. Louis County [which is different and much less plaintiff friendly than St. Louis City], citing Section 508.010.5. However, [plaintiff] was joined with 23 other plaintiffs, two of which were first injured in the City of St. Louis, creating proper venue in the City of St. Louis pursuant to Section 508.010.4.

Id. at *2. The drafters of the venue statute, when considering out-of-state defendants, did not anticipate the courts allowing massive multi-plaintiff complaints. Thus, the statute was capable of being stretched by pro-plaintiff courts so that the "place of agent" provision for out-of-state defendants is effectively nullified by what would otherwise be an unexceptional venue provision concerning in-state tort plaintiffs.

By also refusing to require severance, id. at *5 (not an abuse of discretion, given the same reasons that allowed joinder and venue), Barron puts its imprimatur on the other side's perversion of Missouri joinder/venue provisions and gives free reign to plaintiffs to include one St. Louis City resident among scores of plaintiffs and thereby expand that one person's proper venue in his/her county of residence to every other plaintiff and defendant, even though, if brought separately, venue for neither plaintiff nor defendant would lie in St. Louis City.

So there.

But as the concurrence points out, it doesn't have to be this way:

When [the venue statute is] combined with Missouri Supreme Court Rule 52.05, the result is that lawsuits are filed in Missouri with a minimal number of Missouri plaintiffs joined with a much larger number of non-resident plaintiffs. To the extent that this practice is seen as a problem, it is within the power of the Legislature to "fix it."

Id. at *14 (Richter, J. concurring). Of course, the concurrrence does not mention the maxim against reading enactments to avoid "absurd results." E.g., Pestka v. State, 493 S.W.3d 405, 412 (Mo. 2016) (rejecting construction that "leads to an absurd result"). This begs the question, of course, about what is "absurd" within the context of Missouri jurisprudence.

Not being from Missouri that struck us as a bit odd. In Pennsylvania, separation of powers concerns would preclude legislative amendment of a court rule, but thankfully that doesn't seem to be the case in Missouri. See Mo. Const. art. V §5 ("Any rule may be annulled or amended in whole or in part by a law limited to the purpose.").

We sincerely hope that the Missouri legislature does fix this problem. There is no good reason for Missouri to be such a procedural outlier. Few, if any, other states allow massive joinders of product liability complaints by plaintiffs with nothing in common except that they are suing over injuries (not even the same) allegedly caused by the same product. No state that we know of allows venue to be determined for all plaintiffs and all defendants by an outlier plaintiff from a peculiarly pro-plaintiff venue. Given the state-level election results in Missouri, we think now is as good a time as any for everyone – lawyers and clients – on the right side of the "v." to seek the judicial fix mentioned in the Barron concurrence.

Finally, there's a lot more in Barron. All of it adverse. However, because the merits discussion consists largely of a pro-plaintiff Missouri court misconstruing (or making up) Minnesota law, we'll just list those topics here:

  • A failure to warn can exist by reason of a defendant not providing derogatory comparative risk information about its product (unclear whether the claimed factual basis meets the FDA's standards for comparative claims). Barron, 2016 WL 6596091, at *6.
  • An in-force, FDA-approved boxed warning can be "false and misleading." Id. at *7.
  • A manufacturer's "duty to keep informed of scientific knowledge" includes a duty to publish derogatory comparative risk information. Id. at 10.
  • An in-force, FDA-approved black box warning about the type of injury that the plaintiff suffered could nonetheless be a basis for punitive damages. Id. at *11-12.

We hope that, in future cases, Minnesota courts will give these rulings all the consideration that they merit.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

James Beck
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.